- Home
- CAN vs EBS Comparison
CAN vs EBS Comparison
Compare CAN & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAN
- EBS
- Stock Information
- Founded
- CAN 2013
- EBS 1998
- Country
- CAN Singapore
- EBS United States
- Employees
- CAN N/A
- EBS N/A
- Industry
- CAN Semiconductors
- EBS Biotechnology: Pharmaceutical Preparations
- Sector
- CAN Technology
- EBS Health Care
- Exchange
- CAN Nasdaq
- EBS Nasdaq
- Market Cap
- CAN 384.3M
- EBS 393.9M
- IPO Year
- CAN 2019
- EBS 2006
- Fundamental
- Price
- CAN $0.60
- EBS $6.29
- Analyst Decision
- CAN Strong Buy
- EBS Strong Buy
- Analyst Count
- CAN 5
- EBS 3
- Target Price
- CAN $2.90
- EBS $14.33
- AVG Volume (30 Days)
- CAN 39.0M
- EBS 1.4M
- Earning Date
- CAN 05-20-2025
- EBS 05-07-2025
- Dividend Yield
- CAN N/A
- EBS N/A
- EPS Growth
- CAN N/A
- EBS N/A
- EPS
- CAN N/A
- EBS N/A
- Revenue
- CAN $317,009,000.00
- EBS $965,400,000.00
- Revenue This Year
- CAN $166.98
- EBS N/A
- Revenue Next Year
- CAN $32.96
- EBS $16.07
- P/E Ratio
- CAN N/A
- EBS N/A
- Revenue Growth
- CAN 65.68
- EBS N/A
- 52 Week Low
- CAN $0.53
- EBS $4.02
- 52 Week High
- CAN $3.27
- EBS $15.10
- Technical
- Relative Strength Index (RSI)
- CAN 38.54
- EBS 55.26
- Support Level
- CAN $0.63
- EBS $6.17
- Resistance Level
- CAN $0.73
- EBS $6.68
- Average True Range (ATR)
- CAN 0.07
- EBS 0.37
- MACD
- CAN -0.01
- EBS -0.01
- Stochastic Oscillator
- CAN 7.74
- EBS 57.31
About CAN Canaan Inc.
Canaan Inc is a developer of supercomputing chips and the manufacturer of digital blockchain computing equipment as well as the supplier of the overall scheme for computer software and hardware of digital blockchain. The revenues of the company are derived from the sales of Bitcoin mining machines and related parts.
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company operates across three different segments, namely Commercial, Products, and Services. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.